Association of noninvasive respiratory support with mortality and intubation rates in acute respiratory failure: a systematic review and network meta-analysis

Abstract

Background Noninvasive respiratory support devices may reduce the tracheal intubation rate compared with conventional oxygen therapy (COT). To date, few studies have compared high-flow nasal cannula (HFNC) use with noninvasive positive-pressure ventilation (NPPV). We conducted a network meta-analysis to compare the effectiveness of three respiratory support devices in patients with acute respiratory failure. Methods The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, and Ichushi databases were searched. Studies including adults aged ≥ 16 years with acute hypoxic respiratory failure and randomized-controlled trials that compared two different oxygenation devices (COT, NPPV, or HFNC) before tracheal intubation were included. A frequentist-based approach with a multivariate random-effects meta-analysis was used. The network meta-analysis was performed using the GRADE Working Group approach. The outcomes were short-term mortality and intubation rate. Results Among 5507 records, 27 studies (4618 patients) were included. The main cause of acute hypoxic respiratory failure was pneumonia. Compared with COT, NPPV and HFNC use tended to reduce mortality (relative risk, 0.88 and 0.93, respectively; 95% confidence intervals, 0.76–1.01 and 0.80–1.08, respectively; both low certainty) and lower the risk of endotracheal intubation (0.81 and 0.78; 0.72–0.91 and 0.68–0.89, respectively; both low certainty); however, short-term mortality or intubation rates did not differ (0.94 and 1.04, respectively; 0.78–1.15 and 0.88–1.22, respectively; both low certainty) between NPPV and HFNC use. Conclusion NPPV and HFNC use are associated with a decreased risk of endotracheal intubation; however, there are no significant differences in short-term mortality. Trial registration PROSPERO (registration number: CRD42020139105, 01/21/2020)

First Attempt at Using Electrical Impedance Tomography to Predict High Flow Nasal Cannula Therapy Outcomes at an Early Phase

“…High flow nasal cannula therapy may help avoid invasive mechanical ventilation in patients with hypoxemia (1). Recent studies have indicated that a high flow nasal cannula (HFNC) improves respiratory drive and lung mechanics and enhances CO 2 removal (2,3).…”

Stratifying risk outcomes among adult COVID-19 inpatients with high flow oxygen: The R4 score

“…However, its benefit in mortality is controversial. 8 , 9 In the setting of the current pandemic, HFO has been recommended over the use of non-invasive ventilation NIV 10 , 11 , despite limited evidence regarding its benefit in improving outcomes. Nonetheless, with a global shortage of mechanical ventilators and access to specialized care, HFO may be a useful alternative.…”

Procedural task trainer gaps in emergency medicine: A rift in the simulation universe

“…Learners develop skills through supervised deliberate practice and the provision of feedback. 2,3 Due to a variety of factors, such as the introduction of new technology and changes in standards of care, 4,5 there has been a decrease in the overall number of procedures being performed, particularly some of the higher risk procedures, such as cricothyrotomy, pericardiocentesis, and lumbar puncture. 6 These high-acuity, low-opportunity procedures are increasingly taught via simulation given the lack of exposure in the clinical environment.…”